entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 18:37:23 - browse：49

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Eli Lilly’s Zepbound improved liver scarring in mid

WSS

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Finland to offer bird flu vaccine to select groups of people, a possible global first

Biotech investment managers search for lucrative opportunities

Medical devices makers are asking for forgiveness, not permission

Elevance PBM president out as customers face prescription chaos

Take antibiotics after sex, CDC recommends for certain risk groups

entertainment

entertainment

focus

Walensky prepares to leave CDC — and Congress — behind

Pfizer, Moderna say biotech, pharma drug development is a sprint

Malaria cases in Florida and Texas: Here’s what you need to know

'Patient friction coefficient' can gauge a clinical trial's patient burden

Walensky prepares to leave CDC — and Congress — behind

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Cancer drug shortages should be causing more outrage

This gene therapy has record $4.25 million price. It's saved children.

Trump demands the U.S. pay no more for drugs than other countries … again

Anthony Fauci pushes back on GOP claims during Covid hearing

leisure time

Illumina board agrees to spin off Grail, as divestment plans proceed

Texas board proposes rules on abortion law emergency exemption

How CO2 helps viruses stay alive longer in the air

FDA approves Moderna’s RSV vaccine, its second licensed product

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Data don't support strong claims for Covid

hotspot

knowledge

hotspot

explore